These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 4629509)
1. -Aminolevulinic acid synthetase activity of human bone marrow erythroid cells in various hematological disorders. Takaku F; Yano Y; Aoki Y; Nakao K; Wada O Tohoku J Exp Med; 1972 Jul; 107(3):217-28. PubMed ID: 4629509 [No Abstract] [Full Text] [Related]
2. Bone marrow delta-aminolevulinic acid synthetase activity in hematological disorders. Tanaka M Nagoya J Med Sci; 1977 Jan; 39(1-2):21-31. PubMed ID: 854075 [No Abstract] [Full Text] [Related]
3. Delta-aminolevulinic acid synthetase activity in normal human bone marrow and in patients with idiopathic sideroblastic anemia. Bottomley SS; Tanaka M; Self J Enzyme; 1973; 16(1):138-45. PubMed ID: 4208577 [No Abstract] [Full Text] [Related]
4. Delta-aminolevulinic acid synthetase activity in erythroblasts of patients with sideroblastic anemia. Takaku F; Nakao K Life Sci II; 1971 Jul; 10(13):721-6. PubMed ID: 5561051 [No Abstract] [Full Text] [Related]
5. A case of primary acquired sideroblastic anemia with deficient -aminolevulinic acid synthetase activity in bone marrow erythroblasts. Tanaka M; Ota H Tohoku J Exp Med; 1972 Feb; 106(2):199-206. PubMed ID: 5027484 [No Abstract] [Full Text] [Related]
6. Characterization and measurement of delta-aminolaevulinate synthetase in bone marrow cell mitochondria. Bottomley SS; Smithee GA Biochim Biophys Acta; 1968 Apr; 159(1):27-37. PubMed ID: 4297072 [No Abstract] [Full Text] [Related]
7. delta-Aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia. Hypercatabolism caused by the increased susceptibility to the controlling protease. Aoki Y; Muranaka S; Nakabayashi K; Ueda Y J Clin Invest; 1979 Nov; 64(5):1196-203. PubMed ID: 500806 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow delta-aminolevulinic acid synthetase activity in experimental sideroblastic anemia. Tanaka M; Bottomley SS J Lab Clin Med; 1974 Jul; 84(1):92-8. PubMed ID: 4833846 [No Abstract] [Full Text] [Related]
9. [Delta-aminolevulinic acid synthetase activity in erythroblasts of patients with various hematological disorders (author's transl)]. Takaku F; Aoki Y; Urata G Rinsho Ketsueki; 1973 Dec; 14(0):1303-10. PubMed ID: 4807604 [No Abstract] [Full Text] [Related]
10. [Clinical studies on porphyrin metabolism. 1. Studies on -aminolevulinic acid synthetase]. Tsuneyama H Nihon Ketsueki Gakkai Zasshi; 1971 Oct; 34(5):519-29. PubMed ID: 5170337 [No Abstract] [Full Text] [Related]
11. [A family of hereditary refractory sideroblastic anemia with markedly reduced delta-aminolevulinic acid synthetase activity in bone marrow erythroblasts]. Hirabayashi N; Utsumi M; Nakashima I; Yasuma A; Aoki N Rinsho Ketsueki; 1976 Jan; 17(1):45-50. PubMed ID: 987283 [No Abstract] [Full Text] [Related]
12. Depression of bone marrow delta-aminolaevulic acid synthetase activity in erythroleukaemia. Tanaka M; Hotta T; Yamada H Br J Haematol; 1973 Nov; 25(5):599-606. PubMed ID: 4518625 [No Abstract] [Full Text] [Related]
19. Heme synthesis in four patients with primary acquired sideroblastic anemia. Tanaka M; Ota H; Hotta T Nihon Ketsueki Gakkai Zasshi; 1972 Feb; 35(1):7-19. PubMed ID: 4673856 [No Abstract] [Full Text] [Related]
20. The effect of lead and ferrous and ferric iron on delta-aminolaevulic acid synthetase. Morrow JJ; Urata G; Goldberg A Clin Sci; 1969 Oct; 37(2):533-8. PubMed ID: 4982628 [No Abstract] [Full Text] [Related] [Next] [New Search]